Corruption: CDSCO Dty Drug controller arrested by CBI , suspended by Health Ministry

Published On 2019-08-19 10:42 GMT   |   Update On 2021-08-16 08:28 GMT
New Delhi The Union Health Ministry on Sunday said Deputy Drug Controller Dr Naresh Sharma, posted at the CDSCO headquarters, has been suspended following his arrest by the CBI on charges of corruption.

The Central Drugs Standard Control Organisation (CDSCO) has a zero tolerance policy towards corruption and is committed to act stringently against any such acts, the ministry said in a statement.

" As informed by CBI, Dr. Naresh Sharma, Dy. Drug Controller (I), CDSCO (Hq), New Delhi has been trapped and taken in custody by them on 16.08.2019 and legal investigation under Cr.No. and Section RC-29/2019 u/s 7 of PC Act, 1988 has been initiated. Accordingly, Dr. Naresh Sharma, DDC (I) has been suspended with immediate effect. All stakeholders, public and officers shall take cognizance of the fact that CDSCO has the policy of zero tolerance towards corruption and is committed to act stringently against any act of corruption." the statement issued by the Union Health Ministry stated

Prior to joining CSDCO, Dr Sharma was associated with numerous pharma companies including Dabur, Cadilla Pharma,JK pharmaceuticals. He worked in Research and Development of specialized pharmaceutical dosage form and new products including Tablets, Capsules, liquid orals, Parenteral products and topical preparations etc.
Tags:    
Article Source : ANI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News